TYMP and cancer: Conversely, suppression of TP expression by specific small interfering RNA (siRNA) in cancer cells and low or deficient intratumoural TP activity impaired 5-FU therapeutic efficacy in preclinical studies and in cancer patients, respectively (Salonga et al, 2000; de Bruin et al, 2003; Thanasai et al, 2010).